Overview
Overview
A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
Sponser
Sponser
Jansenn & Jansenn
Principal Investigator
Principle Instigator
Prof Omu Anzala
Abstract
Abstract
This study aims to evaluate the safety, tolerability and immunogenicity of different MVA-BN-Filo and Ad26.ZEBOV vaccine regimens
